Clene (NASDAQ:CLNN) executives used a conference presentation to outline near-term regulatory plans for CNM-Au8 in ...
Ocular Therapeutix (NASDAQ:OCUL) reported positive top-line results from its SOL-1 Phase 3 clinical trial evaluating AXPAXLI ...
The path to the 2025-26 UEFA Champions League final in Budapest, Hungary, is all set.  After the conclusion of the knockout ...
A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...
Adding small or even large amounts of saturation doesn’t have to be bad for you, as we explore how to singe your sonics ...
AMT-130 Huntington’s gene therapy data, FDA Phase III sham-trial push, cash runway, and 2026 catalysts—read now.
It’s rare but some eclipses cause stunning Instagram-worthy visual effects like devil horns, a Cheshire cat smile or diamond ring in the sky.
Viktor Hovland is on a constant, relentless pursuit of perfection, and this is both his greatest strength and biggest weakness. The Norwegian superstar enters the 2026 Arnold Palmer Invitational at ...
Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite ...
The Champions League round of 16 fixtures are now set — and teams even know their possible path to the final. Standout fixtures in the next round include a rematch of the Club W ...
Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite no difference in platelet count recovery End-of-Phase ...
FRAXA's early preclinical support helped establish the calcium-activated potassium ("BK") channel modulator mechanism behind SPG601. FRAXA also supported the development of another BK channel ...